Literature DB >> 6831628

Re: The relationship between serum alkaline phosphatase and vincristine neuropathy.

M L Slevin, V J Harvey, P F Wrigley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6831628     DOI： 10.1007/bf00446229

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  3 in total

1.  Can severe vincristine neurotoxicity be prevented?

Authors:  Z R Desai; H W Van den Berg; J M Bridges; R G Shanks
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

2.  The pharmacokinetics of vincristine in man: reduced drug clearance associated with raised serum alkaline phosphatase and dose-limited elimination.

Authors:  H W Van den Berg; Z R Desai; R Wilson; G Kennedy; J M Bridges; R G Shanks
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

3.  High incidence of vincristine-induced neuropathy in lymphomas.

Authors:  S M Watkins; J P Griffin
Journal:  Br Med J       Date:  1978-03-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.